Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
2008 · Molecular Psychiatry · 443 citations
https://doi.org/10.1038/mp.2008.116
M
Masaki Kato
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
210
Papers
4.0K
Citations
29
h-index
72
i10-index
Masaki Kato is an academic researcher from Hiroshima University. The author has contributed to research in topics: Treatment of Major Depression & Bipolar Disorder and Treatment & Schizophrenia research and treatment. The author has an h-index of 29, co-authored 179 publications.
ORCID: 0000-0001-6727-7272Papers by this author
worksABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder
2007 · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 173 citations
https://doi.org/10.1016/j.pnpbp.2007.09.003
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
2015 · Translational Psychiatry · 139 citations
https://doi.org/10.1038/tp.2015.47
Identifying the Common Genetic Basis of Antidepressant Response
2021 · Biological Psychiatry Global Open Science · 126 citations
https://doi.org/10.1016/j.bpsgos.2021.07.008
Effect of 5‐HT1A gene polymorphisms on antidepressant response in major depressive disorder
2008 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 106 citations
https://doi.org/10.1002/ajmg.b.30783
The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression
2017 · Journal of Affective Disorders · 100 citations
https://doi.org/10.1016/j.jad.2017.06.001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat